LCTX vs LVS · rev $2.8M vs P/E 28, rev $6.74B
Lineage Cell Therapeutics Inc (LCTX) versus Las Vegas Sands Corp (LVS) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Las Vegas Sands Corp (LVS) is a resorts & casinos company listed on US.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
Latest reported LVS revenue for 2026-06-30 was $6.74B. Net income was $913.0M. Revenue was up 88.0% from 2026-03-31 to 2026-06-30. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
LCTX currently screens at market cap $213.6M. LVS currently screens at market cap $35.70B and trailing P/E 28.3.
Not investment advice. Open the LCTX and LVS stock pages for the full models.
Not investment advice.